The market’s reaction to Moderna and Merck's personalized mRNA vaccine for melanoma—a spectacular 177% surge in Moderna’s stock, according to CNBC—is pure adrenaline.
By Dana Whitfield ·
I’ve spent my life scoring things in payroll. I track whether a promise lands on a spreadsheet: who gets hired, at what wage, and if the work remains there five years from now.
By Ray Dombrowski ·
There are moments when the pursuit of superficial beauty seems less like personal choice and more like cultural compulsion.
By Sophie Naimi ·
There is a deep comfort in the architecture of modern life: glass walls separating us from the unpredictable sun, climate control humming softly, and the assumption that because…
By Caroline Ashford ·